Register by Friday, April 25 to Save Up to CNY 2000 or $400 US!
Printed from the IBC Life Sciences Web site on March 12, 2014 6:14 AM ET.
Page location: http://www.ibclifesciences.com/BPIChina/overview.xml
August 19-20, 2014 · Grand Hyatt Shanghai · Shanghai, China
Speaker Interview Podcast with H. Fai Poon, Ph.D., Director of Cell Culture at Hisun Pharmaceutical (Hangzhou) Co., Ltd., China
"We thoroughly enjoyed the program this year and are happy to see the event continuing to grow in size and scope." - Bill Whitford, Thermo Fisher
BioProcess International China is regarded as one of Asia's premier conferences and exhibitions. Attendees have long benefitted from the practical tools and immediately applicable knowledge they gain to improve upstream and downstream development efforts and economic and compliant approaches for scale up and GMP manufacturing.
BioProcess International China 2013 was a great success. We will return back to Shanghai in August 2014.
Find Practical Strategies to Accelerate Your Biologics to Market:
Keynote Presentation: The Current Situation and Analysis of the Design of Biological Product in China
Wu Jun, Trainer, Executive Development Teacher, China's State Food and Drug Administration (SFDA)
Integration of Biologics Formulation & Pre-filled Syringe (PFS) - what you must know in order to achieve best-in-class status in today's global pharmaceutical market
Danny Chou, Pharm.D., Ph.D., MBA, Senior Research Scientist, Biologics, Gilead Sciences, USA
Featured Presentation: Biosimilar mAbs in China - Drivers and Challenges
DQ Wang, Ph.D., Global Biological Development, Bayer HealthCare LLC
Single-use Technologies for Biologics Production
Ting Chen, Ph.D., Senior Scientist, Bioprocess, AlphaMab Co., Ltd., China
Viral Safety Measures in Downstream Processing
Rolf G. Werner, Ph.D., Professor, Industrial Biotechnology, University of Tuebingen, Germany
Improved process economy with non-column purification of monoclonal antibodies
Rui Nian, Ph.D., Research Scientist, Downstream Processing Group, Bioprocessing Technology Institute, A*STAR Singapore
Analytical Strategies for Antibody Drug Conjugates
Gayathri Ratnaswamy, Ph.D., Director, Analytical Formulation Development, Agensys, Inc.
"This conference is great. It's valuable for anyone who what wants to learn about the latest progress and future trends in the field." - Hezhong Liu, Vice President, Beijing Hua'an Innovation Biotechnologies, China
This is your gateway to meet and network with Chinese/Asian drug developers and contract manufacturers to understand where they stand in the field of processing capabilities, as well as find potential business partners and collaborators to develop biosimilars, biobetters, novel biologics or vaccines.
This is your opportunity to learn technical know-how and practical solutions from the experienced scientists and engineers from around the world, as well as hear how to trouble-shoot problems and avoid pitfalls in the quest for higher yield and better quality.
"At this conference, I got information on all aspects of the biologics industry. The emphasis on comparisons between the biologics industry in China and the US was especially useful." - Huilin Zhu, Senior Scientist, Cell Culture PD, Wuxi Apptec, China